Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

A protein called GIS3 is important for the growth of root hairs in Arabidopsis by controlling two genes with the help of certain growth signals.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

Polygenic Score can help predict severe psoriasis and psoriatic arthritis.

A man with a new type of male pattern hair loss that affects the back of the head responded well to common hair loss treatments.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Sinapic acid may help hair growth by activating a specific cell pathway.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Vitamin C derivative helps hair grow longer by making cells produce a growth factor through a specific cellular pathway.

PRP therapy is a promising and effective treatment for hair loss with minimal side effects.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

A new tool simplifies alopecia areata severity scoring but needs validation.

Effective sleep apnea treatment may reverse cognitive decline in Alzheimer's.

PRP injections improve hair density in male hair loss.

Setipiprant did not significantly improve hair growth in men with hair loss.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Fibrodysplasia ossificans progressiva is a rare genetic disorder that causes extra bone growth and symptoms of premature aging.

DHT, a testosterone byproduct, causes male pattern baldness.

Dysregulated lipid metabolism may play a role in male pattern baldness.

PRP shows promise for improving hair growth in early to moderate hair loss but needs standardized methods for consistent results.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Androgenetic alopecia affects many people, impacting quality of life, and treatment focuses on reversing hair follicle miniaturization.

Personalized treatment plans are crucial for effectively managing male pattern baldness.

A molecule called α-ketobutyrate was found to extend lifespan and improve aging-related symptoms in worms and mice by activating certain cellular pathways and may help develop anti-aging treatments for humans.